[Antiaggregants of thrombocytes in ischemic heart disease].
Beloev I
Tomov
I
I
TŭrnovskaR
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D004176:Dipyridamole / Q000494:pharmacology; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008981:Molsidomine; D009599:Nitroprusside / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D013442:Sulfinpyrazone / Q000494:pharmacology; D013558:Sydnones / Q000494:pharmacology; D014700:Verapamil / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D005343:Fibrinolytic Agents; D013558:Sydnones; D009599:Nitroprusside; D004176:Dipyridamole; D014700:Verapamil; D008981:Molsidomine; D001241:Aspirin; D013442:Sulfinpyrazone
Antiagreganti na trombotsitite pri iskhemichna bolest na sŭrtseto.